A bioorthogonal antibody-based chemically-induced-dimerization switch for therapeutic application

Alexander J. Martinko, Hai L. Tran,Erin F. Simonds, Allison L. Cooke,Zhong Huang, Sruthi Raguveer, Judit Pina Agullet, Suchitra Prasad, Catherine Going, Lisa Marshall, Timothy Park, Sunandan Banerjee, Ramsay Macdonald, Mike Jian,Kenneth Ng, Akhila Palakodaty, Manpreet Kaur,Alberto Ponce,Mohammad Tabrizi,Zachary B. Hill

bioRxiv (Cold Spring Harbor Laboratory)(2023)

Cited 0|Views18
No score
Abstract
We present the Indinavir Ligand Induced Transient Engagement switch (IDV LITE Switch), a fully synthetic Chemically Induced Dimerization (CID) system wherein two humanized antibody fragments are heterodimerized by the antiviral drug indinavir. The IDV LITE Switch represents the first CID system made from fully humanized protein components and dimerized by a clinically approved small molecule drug lacking a mammalian target, making it an ideal bioorthogonal molecular switch for application in small-molecule controlled therapeutics. ### Competing Interest Statement All authors are former employees and equity holders in Soteria Biotherapeutics, Inc..
More
Translated text
Key words
antibody-based,chemically-induced-dimerization
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined